During the past decade, Peninsula Cancer Center conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 21 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 18 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peninsula Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Gynecologic Oncology Group" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peninsula Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Augmenix, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Peninsula Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Colorectal Cancer" (3 trials), "Recurrent Breast Carcinoma" (3 trials) and "Stage IIIA Breast Cancer" (3 trials). Many other conditions were trialed in "Peninsula Cancer Center" in a lesser frequency.

Most popular intervention types in "Peninsula Cancer Center" are "Drug" (35 trials), "Other" (35 trials), "Biological" (15 trials), "Procedure" (10 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (10 trials), "Nivolumab" (7 trials), "Computed Tomography" (6 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Peninsula Cancer Center" are 33 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Peninsula Cancer Center". undefined are not yet recruiting, 6 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Peninsula Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Peninsula Cancer Center, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".